Echocardiographic Assessment of Cardiac Valvular Regurgitation With Lorcaserin From Analysis of 3 Phase 3 Clinical Trials
Explore this paper's citation graph
Summary
In 3 prospective placebo-controlled trials with integrated data for 5249 patients, the rate of echocardiographic valvulopathy was similar with lorcaserin and placebo, and may be at least partially influenced by greater weight loss in the lorcasersin group than in the placebo group.
- Type
- article
- Published
- 2013-07-01
- Cited by
- 70
- References
- 30
- OpenAlex
- https://openalex.org/W23661689
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:30295442
Keywords
Latin Americans, Political science, History
References
- Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.
- Drugs and valvular heart disease.
- Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications
- Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.
- Dopamine agonists and the risk of cardiac-valve regurgitation.
- Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study
- A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.
- American Society of Echocardiography recommendations for use of echocardiography in clinical trials.
- Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity.
- Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies.
- Natural History of Valvular Regurgitation 1 Year after Discontinuation of Dexfenfluramine Therapy
- Valvular heart disease and the use of dopamine agonists for Parkinson's disease.
- 5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats.
- Serotonin Transporters, Serotonin Release, and the Mechanism of Fenfluramine Neurotoxicity
- Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities.
- Recommendations for the evaluation of left ventricular diastolic function by echocardiography.
- Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)
- Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography.
- Therapeutic and adverse actions of serotonin transporter substrates.
- Multicenter, placebo-controlled trial of lorcaserin for weight management.
Cited by
- Modern Obesity Pharmacotherapy: Weighing Cardiovascular Risk and Benefit
- Revisiting weight reduction and management in the diabetic patient: Novel therapies provide new strategies
- The 5-HT2C receptor agonist, lorcaserin, and the 5-HT6 receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour
- Review of pharmacotherapy options for the management of obesity
- Pharmacotherapy for the management of obesity.
- Safety and Efficacy of Lorcaserin: A Combined Analysis of the BLOOM and BLOSSOM Trials
- Lorcaserin for the treatment of obesity? A closer look at its side effects
- From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists.
- Characterization of the 5-HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity
- Tolerability and Safety of the New Anti-Obesity Medications
- New Pharmacological Treatments for the Management of Obesity
- Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications
- New medications for treatment of obesity: metabolic and cardiovascular effects.
- The New Era of Drug Therapy for Obesity: The Evidence and the Expectations
- Pharmacotherapy for obesity: novel agents and paradigms
- Lorcaserin Hcl for the treatment of obesity
- Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat
- New centrally acting agents for appetite control: from biological mechanisms to clinical efficacy
- Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys
- European Guidelines for Obesity Management in Adults
Related papers
- Teaching for Cross-Cultural Understanding.
- Cross-cultural Communication in English Language Teaching
- Development of a Cultural Self-Awareness Approach to Instruction in Intercultural Communication. Technical Report 73-17.
- USIA Intercultural Communication Course: 1977 Proceedings.
- Managing Cross-Cultural Communication: Principles and Practice